---
title: "ALK: The ALK-N001 project is still in Phase I clinical trials"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/261752298.md"
description: "ALK announced that its innovative drug project ALK-N001 is currently still in the Phase I clinical trial stage. The company has noted an increase in market attention towards its innovative drug business. On August 26, 2025, ALK signed a strategic cooperation agreement for the ALK-N002 project with Aifang Bio and Qinhuli, and the relevant matters have been approved by the shareholders' meeting. Aifang Bio and Qinhuli are currently undergoing internal approval"
datetime: "2025-10-19T08:18:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261752298.md)
  - [en](https://longbridge.com/en/news/261752298.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261752298.md)
generator: "portal-rs"
---

# ALK: The ALK-N001 project is still in Phase I clinical trials

According to the Zhitong Finance APP, ALK (002940.SZ) announced that the company has noticed an increase in market attention towards its innovative drug business recently. Currently, the company has only one innovative drug project under research, which is the ALK-N001 project. As of the date of this announcement, this project is still in the Phase I clinical trial stage. On August 26, 2025, the company signed a "Strategic Cooperation Agreement and Licensing Agreement" regarding the ALK-N002 project with Aifei (Shanghai) Biopharmaceutical Technology Co., Ltd. (referred to as "Aifei Biotech") and Shanghai Qinhuli Biopharmaceutical Technology Co., Ltd. (referred to as "Qinhuli"). As of the date of this announcement, this matter has been approved by the company's shareholders' meeting, and Aifei Biotech and Qinhuli are still undergoing internal approval procedures

### Related Stocks

- [002940.CN](https://longbridge.com/en/quote/002940.CN.md)

## Related News & Research

- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [Curql invests in pet healthcare platform Wagmo](https://longbridge.com/en/news/296396050.md)
- [The world’s biggest EV battery maker says all 20 plants are carbon neutral](https://longbridge.com/en/news/296132594.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**